JENNIFER TAYLOR: Open Payments
NPI 1487620274 · ABINGDON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,752 in 86 payments from 24 companies in 2025. Trend: 2023 $1,871 · 2024 $2,120 · 2025 $1,752
Food & beverage: $1,752
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 23 | $470 |
| Amgen Inc. | 11 | $152 |
| Medtronic, Inc. | 4 | $149 |
| Abbott Laboratories | 7 | $119 |
| Dexcom, Inc. | 5 | $96 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $69 |
| Insulet Corporation | 3 | $67 |
| Sequel Med Tech, LLC | 2 | $60 |
| Novartis Pharmaceuticals Corporation | 3 | $59 |
| AstraZeneca Pharmaceuticals LP | 3 | $53 |
Products named: Ozempic, MINIMED 780G, FREESTYLE LIBRE 3, Dexcom G6 Transmitter, Rybelsus, REPATHA, JARDIANCE, Omnipod.
Industry payments across VA — which companies pay providers there.
